HomeINNOVACAP › Filing
🔔 Get instant alerts when INNOVACAP files quarterly results on BSE Start free trial →
Innova Captab Limited (INNOVACAP)

Investor Presentation

Filed: 11 Aug 2026, 20:39 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1 FY27 - Revenue grew 34% YoY to ₹470.9 Cr; CDMO Services & Products 32% YoY, Branded Generics 39% YoY - EBITDA rose 33% YoY to ₹75.1 Cr; margin stable at 16.0% - PAT increased 42% YoY to ₹44.1 Cr; margin improved to 9.4% - Jammu facility ramping up steadily with new client onboarding - FY26 financials: Revenue ₹1,630 Cr, EBITDA ₹250 Cr (15.4%), PAT ₹141 Cr (8.6%) - Manufacturing capacity expanding with focus on operational excellence - Strong global presence: 350+ CDMO customers, 60+ countries served - R&D focused with 60+ scientists and advanced facilities - Confident of sustaining growth and profitability with disciplined capital allocation
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 INNOVACAP — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add INNOVACAP to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Innova Captab Limited

Important. The summary above is generated automatically from Innova Captab Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.